Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus
VanEck's concentrated 26-stock portfolio has outpaced Fidelity's broader 334-holding fund over five years, but at a steeper cost and higher volatility.
VanEck's concentrated 26-stock portfolio has outpaced Fidelity's broader 334-holding fund over five years, but at a steeper cost and higher volatility.
BELLINGS Intelligence Score: 10
Why it matters
This is a routine comparative analysis of two healthcare ETFs with no direct impact on credit markets, regulation, or monetary policy, thus of limited significance to sophisticated credit professionals.
Sources
The Motley Fool
Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus
VanEck's concentrated 26-stock portfolio has outpaced Fidelity's broader 334-holding fund over five years, but at a steeper cost and higher volatility.